Repository logo
Log in(current)
Repository logoMIT Open ScholarshipDSpace@MIT
  1. Home
  2. MIT Open Access Articles
  3. MIT Open Access Articles
  4. Clinical validation of a Cas13-based assay for the detection of SARS-CoV-2 RNA

Clinical validation of a Cas13-based assay for the detection of SARS-CoV-2 RNA

Thumbnail Image
Download
Name

COVID-SHERLOCK ms_RR3.pdf

Description
Accepted version
Size

1.66 MB

Format

Unknown

Checksum (MD5)

45855990e701dd428b19699110cbfe95

Thumbnail Image
Download
Name

COVID-SHERLOCK SI_RR2.pdf

Size

2.87 MB

Format

Unknown

Checksum (MD5)

3549174b05f605d3c7dc4d67c9ac26c1

sword-2021-12-13T16:36:33.original.xml (130 B)
Original SWORD entry document
Author(s)
Joung, Julia
•
Ladha, Alim
•
Jin, Xin
•
Gootenberg, Jonathan S
•
Abudayyeh, Omar O.
•
Zhang, Feng
Date Issued
December 1, 2020
Journal
Nature Biomedical Engineering
Publisher
Springer Science and Business Media LLC
Citation
2020. "Clinical validation of a Cas13-based assay for the detection of SARS-CoV-2 RNA." Nature Biomedical Engineering, 4 (12).
Version
Author's final manuscript
Abstract
© 2020, The Author(s), under exclusive licence to Springer Nature Limited. Nucleic acid detection by isothermal amplification and the collateral cleavage of reporter molecules by CRISPR-associated enzymes is a promising alternative to quantitative PCR. Here, we report the clinical validation of the specific high-sensitivity enzymatic reporter unlocking (SHERLOCK) assay using the enzyme Cas13a from Leptotrichia wadei for the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)—the virus that causes coronavirus disease 2019 (COVID-19)—in 154 nasopharyngeal and throat swab samples collected at Siriraj Hospital, Thailand. Within a detection limit of 42 RNA copies per reaction, SHERLOCK was 100% specific and 100% sensitive with a fluorescence readout, and 100% specific and 97% sensitive with a lateral-flow readout. For the full range of viral load in the clinical samples, the fluorescence readout was 100% specific and 96% sensitive. For 380 SARS-CoV-2-negative pre-operative samples from patients undergoing surgery, SHERLOCK was in 100% agreement with quantitative PCR with reverse transcription. The assay, which we show is amenable to multiplexed detection in a single lateral-flow strip incorporating an internal control for ribonuclease contamination, should facilitate SARS-CoV-2 detection in settings with limited resources.
MIT Department
Howard Hughes Medical Institute
Broad Institute of MIT and Harvard
McGovern Institute for Brain Research at MIT
Massachusetts Institute of Technology. Department of Biological Engineering
Massachusetts Institute of Technology. Department of Brain and Cognitive Sciences
Terms of Use
Creative Commons Attribution-Noncommercial-Share Alike
http://creativecommons.org/licenses/by-nc-sa/4.0/
Persistent DSpace Link
https://hdl.handle.net/1721.1/138450.2
DOI of Published Version
https://doi.org/10.1038/s41551-020-00603-x
Repository logo
PrivacyPermissionsAccessibilityContact us
Repository logo
Notify us about copyright concerns.